Glucose antigen is one of the tumor markers in the body, and elevated glycoantigens often appear earlier than the patient’s symptoms, signs, and imaging abnormalities, thus helping to improve prognosis by detecting early tumors and intervening aggressively to treat them before they develop distant metastases. The normal value of glycated antigen 153 is below 28, when it reaches 31 it indicates the elevation of tumor markers, the first consideration is the possibility of breast cancer, which is common in women and is a malignant tumor of the breast, patients may have a family history of breast cancer, early stage may be asymptomatic, as the disease progresses patients will develop breast lumps with irregular edges and poor mobility, usually when painless lumps, non-pregnant women develop nipple overflow, The patient’s breast lump may be asymptomatic as the disease progresses, and the lump has regular edges and is not mobile.
In addition, elevated glucose antigen 153 can also be seen in gastrointestinal tumors such as pancreatic cancer, colon cancer, bile duct cancer, etc. In the absence of symptomatic manifestations and imaging evidence, patients should be regularly reviewed and dynamically observed, and they should also be extra vigilant for the appearance of symptoms such as jaundice, black stool, fresh blood stool and wasting. The patient should be alerted to the presence of jaundice, black stools, bloody stools and weight loss.